We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$9.62B
AUM Growth
+$9.12B
Cap. Flow
+$10.4B
Cap. Flow %
107.78%
Top 10 Hldgs %
35.81%
Holding
968
New
940
Increased
2
Reduced
1
Closed

Top Sells

Rank Stock Value
1
TGNA
TEGNA Inc
TGNA
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 27.77%
2 Financials 20.93%
3 Industrials 11.05%
4 Healthcare 9.88%
5 Communication Services 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROX icon
626
Tronox
TROX
$1.11B
$2.02M 0.02%
+120,376
New +$2.18M
SWTX
627
DELISTED
SpringWorks Therapeutics
SWTX
$2.01M 0.02%
+81,493
New +$2.98M
ARYE
628
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$2M 0.02%
+205,900
New +$2M
BTM
629
DELISTED
Bitcoin Depot
BTM
$1.99M 0.02%
+28,890
New +$2M
NVR icon
630
NVR
NVR
$16.8B
$1.99M 0.02%
+497
New +$2.12M
LITT
631
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
$1.99M 0.02%
+204,759
New +$1.99M
TMCI icon
632
Treace Medical Concepts
TMCI
$284M
$1.99M 0.02%
+138,637
New +$2.34M
ITQ
633
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$1.98M 0.02%
+201,434
New +$1.98M
SDGR icon
634
Schrodinger
SDGR
$1.33B
$1.97M 0.02%
+74,547
New +$2M
EPR icon
635
EPR Properties
EPR
$4.7B
$1.96M 0.02%
+41,799
New +$2.12M
UTHR icon
636
United Therapeutics
UTHR
$22.9B
$1.95M 0.02%
+8,262
New +$1.68M
NFYS
637
DELISTED
Enphys Acquisition Corp.
NFYS
$1.95M 0.02%
+202,230
New +$1.95M
KIDS icon
638
OrthoPediatrics
KIDS
$596M
$1.94M 0.02%
+44,948
New +$2.06M
CNDA
639
DELISTED
Concord Acquisition Corp II
CNDA
$1.93M 0.02%
+200,296
New +$1.94M
HPP
640
Hudson Pacific Properties
HPP
$729M
$1.93M 0.02%
+18,565
New +$2.75M
ONT
641
Onterris Inc
ONT
$530M
$1.93M 0.02%
+57,108
New +$2.39M
EIGR
642
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.92M 0.02%
+10,143
New +$2.04M
TPH
643
DELISTED
Tri Pointe Homes
TPH
$1.91M 0.02%
+113,171
New +$2.22M
SRRA
644
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.85M 0.02%
+33,735
New +$1.77M
RAIN
645
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$1.85M 0.02%
+333,251
New +$1.14M
AXNX
646
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.85M 0.02%
+32,613
New +$1.79M
GKOS icon
647
Glaukos
GKOS
$10.1B
$1.84M 0.02%
+40,492
New +$1.92M
OHI icon
648
Omega Healthcare
OHI
$14.8B
$1.83M 0.02%
+64,979
New +$1.85M
DFLI icon
649
Dragonfly Energy
DFLI
$16.7M
$1.83M 0.02%
+2,005
New +$1.82M
ED icon
650
Consolidated Edison
ED
$40.2B
$1.82M 0.02%
+19,161
New +$1.82M

Similar funds

UBS O'Connor's Q2 2022 Portfolio in Review

As of Q2 2022, UBS O'Connor held 968 positions worth $9.62B, up 1,838% from $496M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

UBS O'Connor deployed $10.4B of net new capital in Q2 2022, opening 940 new positions and adding to 2 existing holdings. Its largest new stake was Rogers Corp: 1,780,443 shares worth $467M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 85% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was TEGNA Inc, an estimated $1.1M trimmed.

  • UBS O'Connor's largest Q2 2022 buy was Rogers Corp: 1,780,443 shares worth $467M.
  • UBS O'Connor added most to Activision Blizzard in Q2 2022, an estimated $107M increase.
  • UBS O'Connor's biggest Q2 2022 reduction was TEGNA Inc, cutting an estimated $1.1M.
  • UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
  • UBS O'Connor opened 940 new positions and closed 0 in Q2 2022.
  • UBS O'Connor's portfolio value rose 1,838% quarter-over-quarter to $9.62B.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.